患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 国名
• 登録日
•  

• Authorised

• An Efficacy and Safety Trial of MK-8931 in Mild to Moderate AD (EPOCH)
• mild to moderate Alzheimer's Disease MedDRA version: 15.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
• Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Portugal, Spain, Turkey, United Kingdom, United States
• 2012-10-02

• Authorised

• OBE022 added-on to atosiban in threatened spontaneous preterm labour, Proof of Concept study
• oral treatment of threatened spontaneous preterm labour in weeks 24 to 34 of pregnancy MedDRA version: 20.1 Level: LLT Classification code 10075863 Term: Preterm labor System Organ Class: 100000004868 ;Therapeutic area: Body processes [G] - Reproductive physiologi cal processes [G08]
• Czech Republic, Finland, Israel, Poland, Russian Federation, Spain, Vietnam
• 2017-08-11

• Authorised

• To evaluate the efficacy and safety of CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer’s Disease (AD)
• Alzheimer's disease MedDRA version: 19.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
• Argentina, Austria, Belgium, Canada, Chile, China, Finland, France, Germany, Hong Kong, Iceland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Portugal, Singapore, South Africa, Spain, Taiwan, United Kingdom, United States
• 2017-03-31

• Authorised

• This is a study to help understand how Baricitinib compares to placebo (a tablet that does not contain any active medicine) in adults with moderate to severe atopic dermatitis, also known as atopic eczema
• Atopic Dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
• Argentina, Australia, Austria, Hungary, Israel, Japan, Korea, Republic of, Poland, Spain, Switzerland
• 2017-10-05

• Authorised

• This is a study to help understand how Baricitinib compares to placebo (a tablet that does not contain any active medicine) in patients with moderate to severe atopic dermatitis, also named atopic eczema
• Atopic Dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
• Czech Republic, Denmark, France, Germany, India, Italy, Japan, Mexico, Russian Federation, Taiwan
• 2017-08-29

• Authorised

• This is a study to help understand how Baricitinib compares to placebo (a tablet that does not contain any active medicine) in patients with moderate to severe atopic dermatitis, also named atopic eczema
• Atopic Dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
• Czech Republic, Denmark, France, Germany, India, Italy, Japan, Mexico, Russian Federation, Taiwan
• 2017-09-04

• Authorised

• A study to help understand how Baricitinib in Combination with Topical Corticosteroids compares to placebo (a tablet that does not contain any active medicine) in patients with moderate to severe atopic dermatitis, also named atopic eczema
• Atopic Dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
• Argentina, Australia, Austria, Germany, Italy, Japan, Korea, Republic of, Poland, Spain, Taiwan
• 2018-09-26

• Authorised

• A study to help understand how Baricitinib in Combination with Topical Corticosteroids compares to placebo (a tablet that does not contain any active medicine) in patients with moderate to severe atopic dermatitis, also named atopic eczema
• Atopic Dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
• Argentina, Australia, Austria, Germany, Italy, Japan, Korea, Republic of, Poland, Spain, Taiwan
• 2018-08-31

• Authorised

• A randomized study to assess efficacy and safety of Anaceptrapib when added to ongoing lipid-lowering therapy.
• Heterozygous Familial Hypercholesterolemia;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
• Canada, Czech Republic, France, Germany, Netherlands, Norway, Russian Federation, Spain, United Kingdom, United States
• 2011-11-18

• Authorised

• This is a long term extention study in patients with Atopic Dermatitis, also named eczema, that helps to understand how Baricitinib works BREEZE-AD1
• Atopic Dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
• Argentina, Australia, Austria, Czech Republic, Denmark, France, Germany, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Russian Federation, Slovenia, Spain, Switzerland, Taiwan
• 2017-09-22